Ecosystem-matched reprogramming of the tumor–immune microenvironment to overcome cancer immunotherapy resistance
Open Access
- 31 July 2026
- journal article
- review article
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1) , 211
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology of Hunan Province (2025JK2004)
- National Science and Technology Major Program of China (2023ZD0506105)
This publication has 124 references indexed in Scilit:
- Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironmentBiomaterials, 2023
- IL-33-ILC2 axis promotes anti-tumor CD8+ T cell responses via OX40 signalingBiochemical and Biophysical Research Communications, 2022
- Conserved pan-cancer microenvironment subtypes predict response to immunotherapyCancer Cell, 2021
- Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatmentCancer Immunology, Immunotherapy, 2021
- Blockade of Lymphangiogenesis Shapes Tumor-Promoting Adipose Tissue InflammationThe American Journal of Pathology, 2019
- PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer PatientsCancer Cell, 2018
- Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune ResponsesCancer Cell, 2016
- Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in MelanomaCancer Cell, 2016
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell ImmunityCancer Cell, 2014
- Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic CellsCancer Cell, 2014